Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.

van As, Nicholas; Griffin, Clare; Tree, Alison; Patel, Jaymini; Ostler, Peter; van der Voet, Hans; Loblaw, Andrew; Chu, William; Ford, Daniel; Tolan, Shaun; Jain, Suneil; Camilleri, Philip; Kancherla, Kiran; Frew, John; Chan, Andrew; Naismith, Olivia; Armstrong, John; Staffurth, John; Martin, Alexander; Dayes, Ian; Wells, Paula; Price, Derek; Williamson, Emily; Pugh, Julia; Manning, Georgina; Brown, Stephanie; Burnett, Stephanie; Hall, Emma

Abstract

Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized prostate cancer is unclear.

Citation

N. van As, C. Griffin, A. Tree, J. Patel, P. Ostler, H. van der Voet, A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, J. Armstrong, J. Staffurth, A. Martin, I. Dayes, P. Wells, D. Price, E. Williamson, J. Pugh, G. Manning, S. Brown, S. Burnett, and E. Hall

Type

Article
Other